December 6, 2018—Avinger, Inc. announced the commercial launch of its Pantheris Lumivascular image-guided atherectomy system in Australia. The company received notice from Australia’s Therapeutic Goods Administration that the Pantheris system has been included on the Australian Register of Therapeutic Goods, which permits distribution in Australia.
Avinger advised that it recently completed an exclusive distribution agreement with Diverse Devices Pty Ltd. for sale and marketing of Avinger’s Lumivascular products in Australia.
According to the company, the device combines real-time intravascular imaging with catheters for the treatment of peripheral artery disease. Lumivascular technology allows physicians to see from inside the artery during an atherectomy procedure by using optical coherence tomographic imaging that is displayed on Avinger’s Lightbox console.
Vikram Puttaswamy, MD, performed the first cases with Pantheris in Australia after regulatory clearance. Dr. Puttaswamy is a vascular surgeon at North Shore Private Hospital in Sydney, Australia. Additional cases were performed by Yew Toh Wong, MD, a vascular surgeon at Flinders Medical Center in Adelaide, Australia. Pantheris was used to successfully treat lesions in five patients primarily in the superficial femoral artery and included a case with in-stent restenosis.
In the company's announcement, Dr. Puttaswamy commented, “Maximizing the channel for blood flow in revascularizing the vessel, while simultaneously minimizing vascular injury is the goal in treating patients with PAD. This new device provides another option for Australian clinicians when treating patients with this serious disease.”
advertisement
Related Articles
A Physician Perspective on Collaborating With Your Hospital’s Value Analysis Committee
Speaking with a physician leader at Atrium Health’s Sanger Heart and Vascular Institute about advocating for physician device preferences and effectively communicating with key stakeholders.
With Frank R. Arko III, MD
Case Report: Aortoiliac Occlusion in a Patient With Severe Claudication
Management with covered balloon-expandable stents provides another option for complex disease.
By Ehrin J. Armstrong, MD, MSc
Case Report: Treating a Long Chronic Total Occlusion in a Patient With CLI
A personalized treatment approach to a challenging case.
By Erik Weekman, BS; Vinayak Subramanian, BS; Ivy Smith, BS; and George L. Adams, MD, MHS, FACC, FSCAI
Current Challenges for the Modern Management of PAD
An overview of contemporary and emerging practices in peripheral artery disease.
By Fanny S. Alie-Cusson, MD; and Jean M. Panneton, MD, FRCSC, FACS
Top 5 Articles From November 2018
Novel Mechanical Thrombectomy Tools for Venous Thromboembolism
Dr. Antonious Attallah and Dr. Herman Kado report on recent FlowTriever and ClotTriever PE and DVT cases, and extracted clot images are presented from recent procedures performed across the United States.
With Antonious Attallah, MD, FACC, FSCAI; and Herman Kado, MD, FACC, FSCAI, RPVI
Treatment Paradigms for Type B Aortic Dissection–Related Malperfusion and Rupture
Assessing the pathophysiology and endovascular treatments for complicated type B aortic dissection with malperfusion or rupture.
By Grace J. Wang, MD, MSCE, FACS
Training for Proficiency in Transradial Access for Lower Extremity Interventions
A stepwise approach to utilizing transradial access for iliac and femoropopliteal interventions.
By Andrew M. T. L. Choong, MBBS, FRCS (Gen Surg), FEBVS (Hons), MFSTEd, FAMS (Gen Surg); Ian J. Y. Wee; Nicholas L. Syn; and Stanley E. K. Loh, MBChB, MRCS, FRCR
Predictions for Transradial Access Capabilities in the Near Future
A discussion of available technology for transradial access in patients with aortoiliac and infrainguinal disease, current limitations, and opportunities for the future.
By Young Joon (Fred) Kwon, MSE; Raghuram Posham, MD, MPA; Rahul S. Patel, MD, FSIR; and Aaron Fischman, MD, FSIR, FCIRSE
Optimal Room Setup for Transradial Access
Tips for patient and equipment positioning to allow safe, successful, and efficient TRA-based interventions.
